Cover Image
Market Research Report
Product code 
1045282

World Market for Blood Screening, 2022

Published: | Kalorama Information | 42 Pages | Delivery time: 1-2 business days

Price

Back to Top
World Market for Blood Screening, 2022
Published: January 5, 2022
Kalorama Information
Content info: 42 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

This new Kalorama Information report, “World Market for Blood Screening”, focuses on the evolving, multibillion dollar global blood screening market. Blood screening is a medical process that scans the blood for infectious diseases or conditions. In developed nations, donated blood is screened for various pathogens. It is a mature market; however, growth comes from new technologies, increased volume and increased testing in developing nations.

Blood screening testing's primary objectives are to monitor the appearance of newly discovered infectious agents in the blood supply, determine the causes of transfusion reactions of unknown etiology, assess the effectiveness of new donor screening methods, and evaluate the donation process to improve the adequacy of the blood supply.

Blood screening diagnostic markets are driven primarily by the aging of developed markets, new test applications and emerging markets, with the last probably the most important factor in an otherwise low-growth category. As developing nations decide to increase blood safety measures, NAT testing will drive growth in the market.

Product Code: 22-052

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW OF BLOOD SCREENING DIAGNOSTICS
  • MARKET OUTLOOK
    • Figure 1-1: Blood Donation Screening Market Distribution by Analyte, 2021
    • Figure 1-2: Whole Blood Donations per 1000 Population, 2013
  • Major Product Activity
  • Immunoassay

CHAPTER 2: BLOOD SCREENING MARKET

  • Figure 2-1: Blood Screening Market, 2016 - 2026 ($B)
  • Figure 2-2: Policy Adoption of NAT for Blood Screening of HCV, HBV and HIV by Select Country
  • IMMUNOASSAY AND NUCLEIC ACID TESTING (NAT) MARKETS
    • Figure 2-3: Blood Screening Sales by Test Method (Immunoassay vs. NAT), 2021 and 2026 ($B)
  • REGIONAL MARKET
    • Table 2-1: Blood Screening Market Distribution by Global Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • Table 2-2: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
    • Table 2-3: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
  • OTHER TRENDS
    • COVID-19
    • Zika Virus
    • Blood and Component Collection
      • Table 2-4: Blood Component Usage for Selected Conditions
      • Table 2-5: Red Blood Cell and Platelet Use by Hospital Services (%)
  • COVID-19 Impact on Plasma Collection
  • Reevaluating Blood Transfusions
    • Table 2-6: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)

CHAPTER 3: BLOOD TYPING AND GROUPING MARKET

  • Manual Blood Typing Methods
  • Automated Blood Typing and Screening Methods
  • Molecular Methods
  • Reducing Blood Typing Errors
    • Table 3-1: Selected Blood Typing and Grouping Innovations
  • Size and Growth of Typing Markets
    • Table 3-2: Global Blood Typing Market, 2021-2026 (Typing) (in $ millions)
  • Blood Typing Market by Geography
    • Table 3-3: Global Blood Typing Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)

CHAPTER 4: TOP COMPANY BRIEFS

  • ABBOTT DIAGNOSTICS
  • CERUS CORPORATION
    • COVID-19
    • GRIFOLS S.A.
  • ORTHO CLINICAL DIAGNOSTICS (ORTHO)
    • Blood Bank
    • Avioq and Ortho Clinical
  • QUOTIENT LIMITED
    • COVID-19
  • ROCHE
    • Blood Bank